Click for best price
Psoriasis Treatment Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Psoriasis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Treatment Drugs. This report contains market size and forecasts of Psoriasis Treatment Drugs in global, including the following market information:
Global Psoriasis Treatment Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Psoriasis Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
TNF Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Psoriasis Treatment Drugs include Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Psoriasis Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psoriasis Treatment Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Psoriasis Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
TNF Inhibitors
Interleukin Inhibitors
Vitamin D Analogs
Corticosteroids
Others
Global Psoriasis Treatment Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Psoriasis Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Oral
Parenteral
Topical
Global Psoriasis Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Psoriasis Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psoriasis Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Psoriasis Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Allergan
Dermira
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen
Galectin Therapeutics
Cellceutix
Bayer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psoriasis Treatment Drugs, market overview.
Chapter 2: Global Psoriasis Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Psoriasis Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psoriasis Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Psoriasis Treatment Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Psoriasis Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psoriasis Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psoriasis Treatment Drugs Overall Market Size
2.1 Global Psoriasis Treatment Drugs Market Size: 2022 VS 2030
2.2 Global Psoriasis Treatment Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Psoriasis Treatment Drugs Players in Global Market
3.2 Top Global Psoriasis Treatment Drugs Companies Ranked by Revenue
3.3 Global Psoriasis Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Psoriasis Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Psoriasis Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psoriasis Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Psoriasis Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Psoriasis Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Psoriasis Treatment Drugs Market Size Markets, 2022 & 2030
4.1.2 TNF Inhibitors
4.1.3 Interleukin Inhibitors
4.1.4 Vitamin D Analogs
4.1.5 Corticosteroids
4.1.6 Others
4.2 By Type - Global Psoriasis Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Psoriasis Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Psoriasis Treatment Drugs Revenue, 2024-2030
4.2.3 By Type - Global Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Psoriasis Treatment Drugs Market Size, 2022 & 2030
5.1.2 Oral
5.1.3 Parenteral
5.1.4 Topical
5.2 By Application - Global Psoriasis Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Psoriasis Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Psoriasis Treatment Drugs Revenue, 2024-2030
5.2.3 By Application - Global Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Psoriasis Treatment Drugs Market Size, 2022 & 2030
6.2 By Region - Global Psoriasis Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Psoriasis Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Psoriasis Treatment Drugs Revenue, 2024-2030
6.2.3 By Region - Global Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Psoriasis Treatment Drugs Revenue, 2018-2030
6.3.2 US Psoriasis Treatment Drugs Market Size, 2018-2030
6.3.3 Canada Psoriasis Treatment Drugs Market Size, 2018-2030
6.3.4 Mexico Psoriasis Treatment Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Psoriasis Treatment Drugs Revenue, 2018-2030
6.4.2 Germany Psoriasis Treatment Drugs Market Size, 2018-2030
6.4.3 France Psoriasis Treatment Drugs Market Size, 2018-2030
6.4.4 U.K. Psoriasis Treatment Drugs Market Size, 2018-2030
6.4.5 Italy Psoriasis Treatment Drugs Market Size, 2018-2030
6.4.6 Russia Psoriasis Treatment Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Psoriasis Treatment Drugs Market Size, 2018-2030
6.4.8 Benelux Psoriasis Treatment Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Psoriasis Treatment Drugs Revenue, 2018-2030
6.5.2 China Psoriasis Treatment Drugs Market Size, 2018-2030
6.5.3 Japan Psoriasis Treatment Drugs Market Size, 2018-2030
6.5.4 South Korea Psoriasis Treatment Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Psoriasis Treatment Drugs Market Size, 2018-2030
6.5.6 India Psoriasis Treatment Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Psoriasis Treatment Drugs Revenue, 2018-2030
6.6.2 Brazil Psoriasis Treatment Drugs Market Size, 2018-2030
6.6.3 Argentina Psoriasis Treatment Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Psoriasis Treatment Drugs Revenue, 2018-2030
6.7.2 Turkey Psoriasis Treatment Drugs Market Size, 2018-2030
6.7.3 Israel Psoriasis Treatment Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Psoriasis Treatment Drugs Market Size, 2018-2030
6.7.5 UAE Psoriasis Treatment Drugs Market Size, 2018-2030
7 Psoriasis Treatment Drugs Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Psoriasis Treatment Drugs Major Product Offerings
7.1.4 Amgen Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Psoriasis Treatment Drugs Major Product Offerings
7.2.4 Allergan Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Dermira
7.3.1 Dermira Company Summary
7.3.2 Dermira Business Overview
7.3.3 Dermira Psoriasis Treatment Drugs Major Product Offerings
7.3.4 Dermira Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Dermira Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Psoriasis Treatment Drugs Major Product Offerings
7.4.4 Eli Lilly Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Psoriasis Treatment Drugs Major Product Offerings
7.5.4 Novartis Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Psoriasis Treatment Drugs Major Product Offerings
7.6.4 Merck Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Psoriasis Treatment Drugs Major Product Offerings
7.7.4 Johnson & Johnson Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Psoriasis Treatment Drugs Major Product Offerings
7.8.4 Pfizer Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Psoriasis Treatment Drugs Major Product Offerings
7.9.4 AstraZeneca Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 AbbVie
7.10.1 AbbVie Company Summary
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Psoriasis Treatment Drugs Major Product Offerings
7.10.4 AbbVie Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.10.5 AbbVie Key News & Latest Developments
7.11 LEO Pharma
7.11.1 LEO Pharma Company Summary
7.11.2 LEO Pharma Business Overview
7.11.3 LEO Pharma Psoriasis Treatment Drugs Major Product Offerings
7.11.4 LEO Pharma Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.11.5 LEO Pharma Key News & Latest Developments
7.12 Biogen
7.12.1 Biogen Company Summary
7.12.2 Biogen Business Overview
7.12.3 Biogen Psoriasis Treatment Drugs Major Product Offerings
7.12.4 Biogen Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.12.5 Biogen Key News & Latest Developments
7.13 Galectin Therapeutics
7.13.1 Galectin Therapeutics Company Summary
7.13.2 Galectin Therapeutics Business Overview
7.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Major Product Offerings
7.13.4 Galectin Therapeutics Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.13.5 Galectin Therapeutics Key News & Latest Developments
7.14 Cellceutix
7.14.1 Cellceutix Company Summary
7.14.2 Cellceutix Business Overview
7.14.3 Cellceutix Psoriasis Treatment Drugs Major Product Offerings
7.14.4 Cellceutix Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.14.5 Cellceutix Key News & Latest Developments
7.15 Bayer
7.15.1 Bayer Company Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Psoriasis Treatment Drugs Major Product Offerings
7.15.4 Bayer Psoriasis Treatment Drugs Revenue in Global Market (2018-2023)
7.15.5 Bayer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Psoriasis Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Psoriasis Treatment Drugs Market Drivers in Global Market
Table 3. Psoriasis Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Psoriasis Treatment Drugs in Global Market
Table 5. Top Psoriasis Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Psoriasis Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Psoriasis Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Psoriasis Treatment Drugs Product Type
Table 9. List of Global Tier 1 Psoriasis Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psoriasis Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Psoriasis Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Psoriasis Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Psoriasis Treatment Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Psoriasis Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Psoriasis Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Psoriasis Treatment Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Psoriasis Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Psoriasis Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Psoriasis Treatment Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Psoriasis Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Psoriasis Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Psoriasis Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Psoriasis Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Amgen Company Summary
Table 31. Amgen Psoriasis Treatment Drugs Product Offerings
Table 32. Amgen Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Allergan Company Summary
Table 35. Allergan Psoriasis Treatment Drugs Product Offerings
Table 36. Allergan Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Allergan Key News & Latest Developments
Table 38. Dermira Company Summary
Table 39. Dermira Psoriasis Treatment Drugs Product Offerings
Table 40. Dermira Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Dermira Key News & Latest Developments
Table 42. Eli Lilly Company Summary
Table 43. Eli Lilly Psoriasis Treatment Drugs Product Offerings
Table 44. Eli Lilly Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Eli Lilly Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Psoriasis Treatment Drugs Product Offerings
Table 48. Novartis Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Psoriasis Treatment Drugs Product Offerings
Table 52. Merck Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Psoriasis Treatment Drugs Product Offerings
Table 56. Johnson & Johnson Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Psoriasis Treatment Drugs Product Offerings
Table 60. Pfizer Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Psoriasis Treatment Drugs Product Offerings
Table 64. AstraZeneca Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. AbbVie Company Summary
Table 67. AbbVie Psoriasis Treatment Drugs Product Offerings
Table 68. AbbVie Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. AbbVie Key News & Latest Developments
Table 70. LEO Pharma Company Summary
Table 71. LEO Pharma Psoriasis Treatment Drugs Product Offerings
Table 72. LEO Pharma Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. LEO Pharma Key News & Latest Developments
Table 74. Biogen Company Summary
Table 75. Biogen Psoriasis Treatment Drugs Product Offerings
Table 76. Biogen Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Biogen Key News & Latest Developments
Table 78. Galectin Therapeutics Company Summary
Table 79. Galectin Therapeutics Psoriasis Treatment Drugs Product Offerings
Table 80. Galectin Therapeutics Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Galectin Therapeutics Key News & Latest Developments
Table 82. Cellceutix Company Summary
Table 83. Cellceutix Psoriasis Treatment Drugs Product Offerings
Table 84. Cellceutix Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Cellceutix Key News & Latest Developments
Table 86. Bayer Company Summary
Table 87. Bayer Psoriasis Treatment Drugs Product Offerings
Table 88. Bayer Psoriasis Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Bayer Key News & Latest Developments
List of Figures
Figure 1. Psoriasis Treatment Drugs Segment by Type in 2022
Figure 2. Psoriasis Treatment Drugs Segment by Application in 2022
Figure 3. Global Psoriasis Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Psoriasis Treatment Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Psoriasis Treatment Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Psoriasis Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Psoriasis Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Psoriasis Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 16. US Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 28. China Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Psoriasis Treatment Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Psoriasis Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Amgen Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Allergan Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Dermira Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eli Lilly Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson & Johnson Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. AstraZeneca Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AbbVie Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. LEO Pharma Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Biogen Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Galectin Therapeutics Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Cellceutix Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Bayer Psoriasis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
